Shanghai Kehua Bio-engineering (002022.SZ) has obtained a medical device registration certificate for the "Cerebrospinal Fluid/ Urine Total Protein Assay Kit".

Shanghai Kehua Bio-engineering (002022.SZ) announced that the company has recently received the "Medical Device Registration Certificate" (in vitro diagnostic reagent) issued by the Shanghai Food and Drug Administration. The product is named "Cerebrospinal Fluid/Urinary Total Protein Measurement Test Kit (Ortho-Tolidine Red Method)". This reagent kit is used by medical institutions for in vitro quantitative determination of the total protein content in human cerebrospinal fluid or urine, for auxiliary diagnostic purposes.